BioWorld - Tuesday, May 5, 2026

BioWorld Science

Jan. 26, 2022

View Archived Issues

BUB1 biallelic mutations seen to cause microcephaly and developmental delay

Read More

STK26 and DPP4 identified as markers tied to severe COVID-19 risk

Read More

Therapeutic CAR T cells generated in the body reduce fibrosis in heart disease model in vivo

Read More

Pro-IL-12 could treat tumors with reduced toxicity compared to recombinant IL-12

Read More

Discovery of VU-6015241, a novel M4 antagonist with promising preclinical profile

Read More

Hefei Amvite Pharmaceutical patents histamine H1 receptor antagonists

Read More

Shanghai Antengene discloses new ATR kinase inhibitors

Read More

Qilu Regor Therapeutics synthesizes new MAP4K1 inhibitors

Read More

Shanghai Medicilon presents new S1PR1 modulators

Read More

Jiangsu Simcere Medical Equipment divulges new PRMT5 inhibitors

Read More

HCW-9218 potentiates antitumor efficacy by reducing TIS-driven proinflammatory phenotype

Read More

IMX-110 + anti-PD-1 extend median survival in genetic pancreatic cancer mouse model

Read More

INmune Bio collaborates with CUHK to evaluate INKmune in nasopharyngeal cancer

Read More

Siga and Bioarchitech collaborate to study Tpoxx with vaccinia-based immunotherapy platform

Read More

Tumorad significantly reduces tumor growth and prolongs survival in colorectal cancer model

Read More

MAP-tau map of interactions shows more than microtubules

Read More